BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15541842)

  • 1. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.
    Lim P; Monin JL; Monchi M; Garot J; Pasquet A; Hittinger L; Vanoverschelde JL; Carayon A; Gueret P
    Eur Heart J; 2004 Nov; 25(22):2048-53. PubMed ID: 15541842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
    Post F; Weilemann LS; Messow CM; Sinning C; Münzel T
    Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.
    Pedrazzini GB; Masson S; Latini R; Klersy C; Rossi MG; Pasotti E; Faletra FF; Siclari F; Minervini F; Moccetti T; Auricchio A
    Am J Cardiol; 2008 Sep; 102(6):749-54. PubMed ID: 18774001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study.
    Bergler-Klein J; Mundigler G; Pibarot P; Burwash IG; Dumesnil JG; Blais C; Fuchs C; Mohty D; Beanlands RS; Hachicha Z; Walter-Publig N; Rader F; Baumgartner H
    Circulation; 2007 Jun; 115(22):2848-55. PubMed ID: 17515464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
    Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
    Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract.
    Fukuda N; Shinohara H; Sakabe K; Nada T; Tamura Y
    J Heart Valve Dis; 2003 May; 12(3):333-40. PubMed ID: 12803333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.
    Detaint D; Messika-Zeitoun D; Avierinos JF; Scott C; Chen H; Burnett JC; Enriquez-Sarano M
    Circulation; 2005 May; 111(18):2391-7. PubMed ID: 15883225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
    Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
    J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Mabuchi N; Hayashi M; Ohnishi M; Sawaki M; Fujii M; Horie H; Sugimoto Y; Kinoshita M
    Eur Heart J; 1999 Dec; 20(24):1799-807. PubMed ID: 10581138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased B-type natriuretic peptide is associated with an abnormal blood pressure response to exercise in asymptomatic aortic stenosis.
    Van Pelt NC; Kerr AJ; Legget ME; Pasupati S; Whalley G; Wong S; Zeng I; Stewart RA
    Int J Cardiol; 2008 Jul; 127(3):313-20. PubMed ID: 18077013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
    J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
    Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
    Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.
    Rabus MB; Kirali K; Kayalar N; Tuncer EY; Toker ME; Yakut C
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):41-6. PubMed ID: 19196573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.